The interrelation of the angiotensin and endothelin systems on the modulation of NAD(P)H oxidase.
The NAD(P)H oxidase is an enzyme assembled at the cellular membrane able to produce superoxide anion from NADH or NAD(P)H (nicotinamide adenine dinucleotide phosphate). It is one of the main sources of superoxide anion in cardiovascular tissues and its role in a variety of cardiovascular disorders such as atherosclerosis, cardiac hypertrophy, and endothelial dysfunction was recently proposed. Although, many factors and receptors were shown to lead to the activation of the enzyme, particulary the type 1 angiotensin receptor, the pathways involved are still widely unknown. Despite the identification of factors such as c-Src and protein kinase C implicated in the acute activation of NAD(P)H oxidase, the signalling involved in the sustained activation of the enzyme is probably far more complex than was previously envisioned. In this review, we describe the role of endothelin-1 in NAD(P)H oxidase signalling after a sustained stimulation by angiotensin II. Since most pathologies caused by an NAD(P)H oxidase overactivation develop over a relatively long period of time, it is necessary to better understand the long-term signalling of the enzyme for the development or use of more specific therapeutic tools.
Laplante
Marc-André
MA
Research Group on Autonomic Nervous System, Department of Physiology, Faculty of Medicine, Université de Montréal, Succursale Centre-ville, Canada.
de Champlain
Jacques
J
D000804:Angiotensin II / Q000378:metabolism*; D000818:Animals; D002318:Cardiovascular Diseases / Q000378:metabolism; D019332:Endothelin-1 / Q000378:metabolism*; D006801:Humans; D019255:NADPH Oxidases / Q000378:metabolism*
D019332:Endothelin-1; D000804:Angiotensin II; D019255:NADPH Oxidases